Call Options Transactions Made in Q2 2023 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q2 2023. The information is specifically focused on institutions that hold call options of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
CALL |
24.5KNew |
$288K - $355K
|
24.5K
$311K
|
|
|
Aug 08, 2023
Q2 2023
|
Belvedere Trading LLC
|
BUY
|
CALL |
2.2KNew |
$25.8K - $31.8K
|
2.2K
$27.9K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-3.3K- 16.34% |
$38.7K - $47.8K
|
16.9K
$214K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-16.4K- 31.3% |
$193K - $237K
|
36K
$457K
|